Shyam Pattabiraman

Shyam is CFO at Jubilant Therapeutics Inc. that he helped carve out from the parent company Jubilant Life Sciences and set up as a standalone U.S. based biotech venture in 2019. Shyam is also involved in other initiatives at Jubilant such as corporate venture investing, digital and innovation.

Earlier he managed the strategy office at a leading India based conglomerate where he helped scale a new business and managed a successful M&A exit valued at over a billion dollars. Prior to Shyam's industry stints, he spent most of his career as a management consultant at PwC – advising startups and leading global companies in strategy. Shyam has spoken at various conferences and is an active participant in the World Economic Forum community in addition to authoring over fifty thought leadership publications.

He is a graduate of London School of Economics and State University of New York.